Dr. Reddy's Laboratories
174 hedge funds and large institutions have $1.37B invested in Dr. Reddy's Laboratories in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 76 reducing their positions, and 24 closing their positions.
6% less funds holding
Funds holding: 186 → 174 (-12)
6.7% less ownership
Funds ownership: 64.24% → 57.54% (-6.7%)
8% less capital invested
Capital invested by funds: $1.48B → $1.37B (-$118M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 76
42% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 24
59% less call options, than puts
Call options by funds: $791K | Put options by funds: $1.92M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.3M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$9.05M |
| 3 |
Neuberger Berman Group
New York
|
+$6.28M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$5.9M |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$3.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$33.6M |
| 2 |
Morgan Stanley
New York
|
-$22.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$17.9M |
| 4 |
Ninety One (UK)
London,
United Kingdom
|
-$10.6M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.86M |
RDY Hedge Fund Activity: Q4 2020 in Review
174 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2020, worth a combined $1.37B — down 8% from $1.48B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of RDY and 14 opened new positions — a net loss of 10 holders — while 76 trimmed existing stakes and 48 added.
The largest buyer was Millennium Management, adding an estimated $18.3M. The largest seller was Goldman Sachs, cutting an estimated $33.6M.
- 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2020, down from 186 in Q3 2020.
- Funds reported $1.37B of Dr. Reddy's Laboratories stock for Q4 2020, down 8% quarter-over-quarter.
- 14 funds opened new Dr. Reddy's Laboratories positions in Q4 2020 and 24 closed out, a net change of -10 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2020 was Millennium Management, an estimated $18.3M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2020 was Goldman Sachs, an estimated $33.6M sold.
Based on aggregated 13F filings for Q4 2020.